Axcelis Technologies, Inc. is a company dedicated to the creation, production, and maintenance of specialized ion implantation and other essential processing machinery used in the fabrication of semiconductor chips. Operating internationally, its presence extends across North America, Europe, and Asia. The firm offers a wide array of implanter technologies, such as high-energy, high-current, and medium-current systems, designed to meet diverse application needs. Furthermore, Axcelis provides extensive post-sales support and lifecycle solutions, including the sale of pre-owned equipment, replacement parts, system upgrades, ongoing maintenance, and client instruction. It directly furnishes its advanced equipment and services to microchip manufacturers through its own dedicated sales personnel. Founded in 1978, Axcelis Technologies has its corporate headquarters situated in Beverly, Massachusetts.
CEO: Russell J. Low. Company website
Axcelis Technologies, Inc. (ACLS) trades at $109.32, up 4.51% on the day, as of Sep 20, 2026 14:58 UTC.
Axcelis Technologies, Inc. has a market capitalisation of $3.36B, calculated from the live ACLS share price and shares outstanding.
ACLS trades at a trailing P/E of 36.68, from earnings per share of $2.98 over the last twelve months.
Axcelis Technologies, Inc. generated revenue of $866.07M over the trailing twelve months, which puts the stock at 3.88 times sales.
ACLS has traded between $73.60 and $193.78 over the past 52 weeks, and the last price is 43.6% below that high.
Yes. Axcelis Technologies, Inc. keeps 10.71% of revenue as net income over the trailing twelve months.
Wall Street analysts rate ACLS Buy, with an average price target of $140.00, 28.1% above the current price.
Axcelis Technologies, Inc. is classified under the Technology sector and the Semiconductors industry, and is domiciled in US.
Russell J. Low is the chief executive of Axcelis Technologies, Inc., which employs 1,465 people.
QFI Terminal shows ACLS with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open ACLS in Terminal See plans